2022 Speakers Abhishek Srivastava VP, Cell Therapy Development Athenex Alba Gonzalez Director of Research Senti Biosciences Aman Singh Associate Director Clinical Pharmacology M&S, Cell Therapy Takeda Anahid Jewett Professor & Director Tumor Immunology Laboratory UCLA Anders Holm Chief Operating Officer Zelluna Immunotherapy Andre Kunert Principal Scientist Sanofi Arndt Schottelius Chief Scientific Officer Affimed Austin Bigley VP Research & Development Indapta Therapeutics Ayman Kabakibi Chief Operating Officer Wugen Beau Webber Assistant Professor University of Minnesota Björn Önfelt Professor Karolinsk Institutet Bradley Glover EVP & Chief Technology Officer Celularity Branden Moriarity Principal Investigator University of Minnesota Brian Garrison Director Senti Biosciences Caimei Zhang Senior Research Investigator University of Pennsylvania Christian Capitini Associate Professor, Pediatrics University of Wisconsin-Madison Christina Coughlin CEO Cytoimmune Christopher Nowers CEO ONK Therapeutics Dan Kemp CEO Wugen Debora Barton Chief Medical Officer Carisma Therapeutics Don Healey Chief Technology Officer Adicet Bio Eliot Bourk CBO Chimeric Therapeutics Emily Levy Senior Scientist Merck Emily Mace Assistant Professor of Pediatric Immunology Columbia University Evren Alici Head of Cell & Gene Therapy Group Karolinska Institutet Ezequiel Zylberberg VP Product Development and Planning Akron Biotech Gregory Fiore CEO Exacis Biosciences Hans-Gustaf Ljunggren Professor Karolinska Institutet Heather Stefanski Vice President, Medical Services The National Marrow Donor Program®/Be The Match® James Trager Chief Scientific Officer NKarta Jeffrey Miller Professor of Medicine University of Minnesota Jennifer Dashnau Head of Analytical Development & Quality Control Century Therapeutics Jode Goodridge Associate Director Fate Therapeutics Johan Liwing CEO XNK Therapeutics Joseph Gold VP Technical Operations Catamaran Bio Kai Pinkernell Chief Medical Officer glycostem Kanya Rajangam Chief Medical Officer NKarta Therapeutics Kate Rochlin VP Operations & Innovations IN8bio Kevin Flynn R&D Manager Bio-Techne Kimberly Schluns Senior Director Research Kite: A Gilead Company Marcel Zwaal CEO Gadeta Marcia Blackmoore CMC Project Leader, Genomic Medicines Unit Sanofi Mark Lowdell Chief Scientific Officer INmune Bio Mark Moore CEO Gempharmatech US Mary Reilly Chief Operating Officer ONK Therapeutics Melissa Berrien-Elliott Instructor Washington University School of Medicine, St. Louis Melody Eble Vice President Global Regulatory Affairs Century Therapeutics Michael DeRidder SVP Corporate Strategy and New Product Planning Catamaran Bio Michael O’Dwyer Founder & CSO ONK Therapeutics Neil Sheppard Adjunct Associate Professor University of Pennsylvania Nicholas Boyd CDO Cartherics Nicholas Huntington Professor Biochemistry & Molecular Biology Monash University Nina Möker R&D Reagents Manager Allogeneic Cell Therapy Miltenyi Biotec Peter Flynn Co-Founder & COO Artiva Bio Philip Lee Chief Technology Officer Senti Biosciences Ralph Brandenberger SVP Tech Ops NKarta Therapeutics Rizwan Romee Associate Professor of Medicine Dana-Farber Cancer Institute Robert Igarashi Vice President Discovery & Preclinical Development Sanofi Sandro Matosevic Assistant Professor Purdue University Serhat Gumrukcu Executive Director & Director of Research Seraph Research Institute Stacey Cranert Director, Immuno-Oncology Poseida Therapeutics Stanley Frankel Chief Medical Officer Cytovia Therapeutics Tanima Abedin Senior Field Application Specialist ScaleReady Todd Fehniger Professor of Medicine Washington University School of Medicine, St. Louis Uriel Moreno Scientist Johnson & Johnson Volker Huppert CDO glycostem Will Singleterry Commercial Director - Immuno-Oncology LUMICKS William Sandborn Co-Founder & CMO Shoreline Biosciences
